TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/15/23 14:08 | 3/13/23 | MNK | Mallinckrodt Plc | Health | Drug | Pharmaceutical Preparations | Olafsson Sigurdur O | MO | DO | P,CEO | P | 25 | 8.37 | 0 | 3 | 1 | 228 | D | |||||||||||||||
11/13/13 20:19 | 11/11/13 | ACT | Actavis Plc | L2 | Health | Drug | Pharmaceutical Preparations | Olafsson Sigurdur O | L2 | DO | P-ACTAVI | S | -3,997 | 159.87 | 0 | -25 | -26 | 72 | D | ||||||||||||||
10/2/13 21:13 | 9/30/13 | ACT | Actavis, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Olafsson Sigurdur O | NJ | O | P-Global | M.d | 13,029 | 86.86 | 0 | 150 | 0 | D | |||||||||||||||
8/13/13 18:10 | 8/2/13 | ACT | Actavis, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Olafsson Sigurdur O | NJ | O | P-Global | S.a | -610 | 135.47 | 0 | -5 | -5 | 85 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |